The treatment of Cushing's disease
R Pivonello, M De Leo, A Cozzolino… - Endocrine …, 2015 - academic.oup.com
Abstract Cushing's disease (CD), or pituitary-dependent Cushing's syndrome, is a severe
endocrine disease caused by a corticotroph pituitary tumor and associated with increased …
endocrine disease caused by a corticotroph pituitary tumor and associated with increased …
Cushing's syndrome
Chronic exposure to excess glucorticoids results in diverse manifestations of Cushing's
syndrome, including debilitating morbidities and increased mortality. Genetic and molecular …
syndrome, including debilitating morbidities and increased mortality. Genetic and molecular …
Treatment of Cushing's syndrome: an endocrine society clinical practice guideline
LK Nieman, BMK Biller, JW Findling… - The Journal of …, 2015 - academic.oup.com
Objective: The objective is to formulate clinical practice guidelines for treating Cushing's
syndrome. Participants: Participants include an Endocrine Society-appointed Task Force of …
syndrome. Participants: Participants include an Endocrine Society-appointed Task Force of …
Cushing's syndrome: epidemiology and developments in disease management
ST Sharma, LK Nieman, RA Feelders - Clinical epidemiology, 2015 - Taylor & Francis
Cushing's syndrome is a rare disorder resulting from prolonged exposure to excess
glucocorticoids. Early diagnosis and treatment of Cushing's syndrome is associated with a …
glucocorticoids. Early diagnosis and treatment of Cushing's syndrome is associated with a …
Cushing's syndrome
J Newell-Price, X Bertagna, AB Grossman, LK Nieman - The Lancet, 2006 - thelancet.com
Cushing's syndrome results from lengthy and inappropriate exposure to excessive
glucocorticoids. Untreated, it has significant morbidity and mortality. The syndrome remains …
glucocorticoids. Untreated, it has significant morbidity and mortality. The syndrome remains …
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement
BMK Biller, AB Grossman, PM Stewart… - The Journal of …, 2008 - academic.oup.com
Objective: Our objective was to evaluate the published literature and reach a consensus on
the treatment of patients with ACTH-dependent Cushing's syndrome, because there is no …
the treatment of patients with ACTH-dependent Cushing's syndrome, because there is no …
Cushing's disease: pathobiology, diagnosis, and management
RR Lonser, L Nieman, EH Oldfield - Journal of neurosurgery, 2017 - thejns.org
Cushing's disease (CD) is the result of excess secretion of adrenocorticotropic hormone
(ACTH) by a benign monoclonal pituitary adenoma. The excessive secretion of ACTH …
(ACTH) by a benign monoclonal pituitary adenoma. The excessive secretion of ACTH …
Mortality in patients with pituitary disease
M Sherlock, J Ayuk, JW Tomlinson… - Endocrine …, 2010 - academic.oup.com
Pituitary disease is associated with increased mortality predominantly due to vascular
disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor …
disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor …
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
RA Feelders, SJ Pulgar, A Kempel… - European journal of …, 2012 - academic.oup.com
Objective Cushing's disease (CD) is a rare endocrine disorder characterized by excess
secretion of ACTH due to a pituitary adenoma. Current treatment options are limited and …
secretion of ACTH due to a pituitary adenoma. Current treatment options are limited and …
Management of hormone-secreting pituitary adenomas
Pituitary adenomas are one of the most common primary central nervous system tumors and
have an estimated prevalence of 17%. Approximately half of pituitary adenomas secrete …
have an estimated prevalence of 17%. Approximately half of pituitary adenomas secrete …